Back to top

Image: Bigstock

Is Genesis Healthcare (GEN) Stock Outpacing Its Medical Peers This Year?

Read MoreHide Full Article

Investors focused on the Medical space have likely heard of Genesis Healthcare (GEN - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of GEN and the rest of the Medical group's stocks.

Genesis Healthcare is a member of the Medical sector. This group includes 888 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. GEN is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for GEN's full-year earnings has moved 37.42% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Based on the most recent data, GEN has returned 9.32% so far this year. Meanwhile, stocks in the Medical group have gained about 3.45% on average. This means that Genesis Healthcare is performing better than its sector in terms of year-to-date returns.

To break things down more, GEN belongs to the Medical - Nursing Homes industry, a group that includes 5 individual companies and currently sits at #63 in the Zacks Industry Rank. On average, stocks in this group have gained 11.69% this year, meaning that GEN is slightly underperforming its industry in terms of year-to-date returns.

GEN will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Genesis Healthcare, Inc. (GEN) - free report >>

Published in